Should the transaction complete, J&J will inherit Atraverse’s radiofrequency system for simplifying access to the heart’s ...

Adagio Medical Holdings, Inc. ADGM shares are up during Monday’s premarket session following the announcement of positive ...

Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation ...

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

Loyola Medicine is the only center in the Midwest enrolling patients in a landmark clinical trial of a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia.

A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced ...

Adagio Medical reports positive pivotal results for vCLAS Ventricular Ablation System: Laguna Hills, California Tuesday, April 28, 2026, 17:00 Hrs [IST] Adagio Medical Holdings, I ...

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive procedure called ablation is as effective as surgery for treating small ...

Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Aaron ...